We chose COL4A1, COL6A3, spondin-2 (SPON2) and FLNC for further analysis for their high abundance (peptide count), high “fold change” and less chances being identified in colon cancer cell lines (Supplementary Table 2). The gene discussed is SPON2; the disease is malignant colon neoplasm.